Call for Papers

61st ASH Annual Meeting & Exposition

Eligibility

To submit an abstract, the following criteria must be met

• At least one of the authors must be an ASH member, who has paid the current membership dues.

  If none of the abstract authors is an ASH member, the abstract must be sponsored by a current ASH member or it will not be reviewed. ASH members are urged to use their judgment in restricting sponsorship to a reasonable number of abstracts, keeping in mind that they are endorsing the authenticity and quality of each abstract that they sponsor.

• Research and/or studies must fit into one of the ASH 2019 Abstract Review Categories.
• Updated analyses will be considered only if the abstract is a significant extension of previously published work. The author must provide an explanation to show how the abstract contains significant new information.

  *Note: Abstracts submitted to other ASH meetings (e.g., the 2019 Meetings on Lymphoma and Hematologic Malignancies) are exempted from the above meeting-size restriction and are eligible to be re-submitted to the 2019 ASH Annual Meeting.

Any of the following criteria will make an abstract ineligible for presentation at the ASH annual meeting

• Data are publicly available via major search engines (such as PubMed, Google Scholar, etc.);
• Data are accepted for publication before the abstract submission closing date;
• Data have been or are to be presented at a meeting of 1,000 or more participants before the ASH annual meeting*
• Data are to be presented at an ASH Friday Satellite Symposium.

Responsibilities of the Presenting Author

• The first author listed for each abstract serves as the presenting author and as the primary contact for all correspondence regarding the abstract, unless otherwise specified under the "Contact Information" section of the online abstract submission system.
• The presenting author must be one of the co-authors listed on the submitted abstract.
• The presenting author is responsible for the following:
• Ensuring that all authors have read the abstract and agreed to be co-authors. Failure to get approval from all authors will result in rejection of the abstract.
• Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by ASH.
• Obtaining all the conflict of interest disclosure and copyright transfer information from co-authors.
• Forwarding all correspondence to all co-authors, including the ASH policies and guidelines, and the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support for Continuing Medical Education (CME).

Technical Requirements

The electronic submission system is compatible with PC Windows and Apple computers and with most browsers, including Google Chrome, Mozilla Firefox, Internet Explorer, Safari, and Netscape.

Before you Begin

Have the following information available:

Submission Process

FAQS

Please consider the following before submitting your abstract to the ASH Annual Meeting:

• Q: What is the submission deadline for the abstracts?
  A: The deadline for all abstracts is August 1, 2019 at 11:59 p.m. PDT. Submissions that are incomplete at this time will be rejected without review.
• Q: Can I still submit an abstract if I presented it at another scientific meeting or submitted it to a journal?
  A: Any of the following criteria will make an abstract ineligible for presentation at the ASH annual meeting:
  • Data are publicly available via major search engines (such as PubMed, Google Scholar, etc.);
  • Data are accepted for publication before the abstract submission closing date;
  • Data have been or are to be presented at a meeting of 1,000 or more participants before the ASH annual meeting*
  • Data are to be presented at an ASH Friday Satellite Symposium.

  Data from the long-term follow-up of previously presented clinical trials may be submitted only if significant new information can be shown. In this case, please use the Updated Analyses section of the abstract form to explain the significance of the new data. The reviewers will have this information available during their evaluation.

  *Note: Abstracts submitted to other ASH meetings (e.g., the 2019 Meetings on Lymphoma and Hematologic Malignancies) are exempted from the above meeting-size restriction and are eligible to be re-submitted to the 2019 ASH Annual Meeting.

• Q: How long can the abstracts be?
  A: The abstracts are limited to a maximum of 3,800 characters. Note that this character count does not include spaces. Figures are not included in the character count.
• Q: May I include tables in my abstract?
  A: Yes, but we now ask that any tables that you wish to include must be uploaded as an image. You will not be allowed to paste a table directly into the text of the abstract, but rather you must include it as an image in the appropriate place and use the Upload method. To convert a table to an image, we recommend taking a screenshot of the table. If using a PC, use the Snipping Tool or the Print Screen button. If using a Mac, press Command-Shift-4.
• Q: If I have images in my abstract, what resolution should my images be?
  A: We require a minimum of 300 dpi for all uploaded images. This will insure proper resolution for display.
• Q: How many abstracts can a single author submit?
  A: There is no set limit as to the number of abstracts a single author can submit.
• Q: How many authors can contribute to a single abstract?
  A: There is no set limit to the number of authors who can contribute to a single abstract.
• Q: Do all authors on an abstract have to submit their Conflict-of-Interest disclosures to ASH? How should they do that?
  A: The submitting author must manually enter disclosure information for all authors into the online abstract submission form. Authors must disclose all relationships they may have, regardless of their relevance to an abstract. If an author's COI disclosure form populates with information already supplied, we strongly urge you to use this existing information for that person. If you are aware of a relationship that should be added to that disclosure, you may do so, and the update will be applied all of that individual's disclosures for the entire meeting. Please do NOT delete any existing disclosure information if you are not the person in question. You may wish to use this sample form to collect disclosure information from your coauthors. (Please note that this form should NOT be sent to ASH; you are responsible for entering the information on the form into the online abstract submission system for every author.)
• Q: What if I am not able to submit my abstract at this time?
  A: ASH allows for the submission of late-breaking abstracts, covering ground-breaking research results that were not available by the regular submission deadline. Please note that only six late-breaking abstracts will be accepted for presentation, regardless of how many are submitted. Late-breaking Abstracts may be submitted between October 18 and October 30, 2019.
• Q: What if I need to withdraw my abstract?
  A: The deadline to withdraw an abstract is September 21. Abstracts cannot be withdrawn after this deadline, and will appear in all meeting publications and in the abstracts issue of Blood.
• Q: When will I know if my abstract has been accepted?
  A: You will receive an e-mail in early-October notifying you if your abstract has been accepted and whether you are invited to present it at the Annual Meeting.
• Q: When will my accepted abstract be published?
  A: Abstracts that are accepted for presentation will be made available online in early November on the ASH annual meeting Program Web site. They will also be published in a mid-November issue of Blood.